Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAL: Vitamins to Slow Alzheimer's
NCT00056225Phase 3Completed
- Sponsor
- National Institute on Aging
- Start
- Jan 2003
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of folate, pyridoxine and vitamin b12 in Alzheimer's disease (AD) (2 arms), sponsored by National Institute on Aging. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 18 months. Started Jan 2003; status: completed.
02
Drugs
folatepyridoxinevitamin b12
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00056225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056225.